Meet ZERONA Results

Our goal is to provide safe and effective health and wellness products to our physician partners. With this goal in mind all of our products are backed by the highest quality of clinical research. The low-level laser technology utilized by ZERONA has been researched by Erchonia and published in peer reviewed journals. All studies have been completed with the Erchonia laser. ZERONA is FDA Cleared 510 (k) for the safe and effective circumferential reduction of the hips, waist and thighs.

FDA Clearance
DEPARTMENT OF HEALTH & HUMAN SERVICES (2010)

“After review of the information submitted in the petition FDA has determined that the Erchonia ML Scanner indicated for use as a non-invasive dermatological aesthetic treatment for the reduction of circumference of hips, waist, and thighs can be classified in class II with the establishment of special controls. FDA believes that class II special controls provide reasonable assurance of the safety and effectiveness of the device type.”

DOWNLOAD COMPLETE JOURNAL ARTICLE

Efficacy of Non-Invasive Body Contouring
LASERS IN SURGERY & MEDICINE 41:799 – 809 (2009)

Results: Participants in the treatment group demonstrated an overall reduction in total circumference across the hips, waist and thighs of 3.51 inches in two weeks.

Study Design: 67 volunteers participated in a double-blind, multi-site, placebo controlled study.

DOWNLOAD COMPLETE JOURNAL ARTICLE

Depth of Fat Liquefaction
THE AMERICAN JOURNAL OF COSMETIC SURGERY VOL. 18 NO. 3 (2001)

Results: The MRI revealed that at this particular time 100% of the fat was interstitial space and the transitory pore was now open.

Study Design: 3 volunteers were evaluated prior to infiltrating the subcutaneous tissue with tumescent fluid with T1 and T2 sequences.

DOWNLOAD COMPLETE JOURNAL ARTICLE

Fat Liquefaction: Effect of Low-Level Laser Therapy on Adipose Tissue
PLASTIC & RECONSTRUCTIVE SURGERY (2002)

Results: Scanning electron microscopy demonstrated that after 6 minutes of Low-Level Laser exposure fat was completely removed in the interstitial space. Some disruption of the connective tissue was also observed. Other structures, such as the capillaries and the remaining interstitial space, were preserved.

Study Design: In-vitro human adipocyte cultures were developed and then irradiated.

DOWNLOAD COMPLETE JOURNAL ARTICLE

Reducing Pain After Breast Augmentation
THE AMERICAN JOURNAL OF COSMETIC SURGERY (2009)

Results: 74% of test group patients met the success criteria of less than 30 on the VAS at 24 hours after procedure. Only 37% of control group patients met the success criteria of less than 30 on the VAS at 24 hours after procedure. The average post procedure score was 15.3 points lower in the test group vs. the placebo group at 24 hours.

Study Design: 104 volunteers participated in a placebo-controlled, double-blind, randomized study.

DOWNLOAD COMPLETE JOURNAL ARTICLE

Enhancing Ease of Liposuction Procedures
THE AMERICAN JOURNAL OF COSMETIC SURGERY (2004)

Results: Forty-three percent more test-group subjects than placebo-group subjects recorded a discomfort level of less than 30 on the VAS at 24 hours after the liposuction procedure was completed, exceeding the pre-established target of a 30% difference between test and control group of 30%. The average VAS degree of discomfort rating at 24-hours post procedure for test group subjects was 22.85 points lower.

Study Design: 36 volunteers participated in a placebo-controlled, double-blind, randomized study.

DOWNLOAD COMPLETE JOURNAL ARTICLE

Non-invasive Body Contouring with Radiofrequency, Ultrasound, Cryolipolysis, and Low-Level Laser
Clinics In Plastic Surgery (2011)

Overview: Discussion of current non-invasive body contouring modalities including suction massage devices, radio frequency, high-frequency focused ultrasound, cryolipolysis, and low-level laser therapy (ZERONA).

Basic Science: Mulholland et al. (2011) described the adipose tissue as an important cell involved in energy storage, hormonal regulation, and a host of other endocrinologcial functions. With this characterization, ZERONA represents the only technology that prevents cell apoptosis, in turn, preserving this endocrine organ.

DOWNLOAD COMPLETE JOURNAL ARTICLE

The Use of Low-Level Laser Therapy for Noninvasive Body Contouring
Aesthetic Medicine (2011)

ZERONA is featured in the highly-regarded book Aesthetic Medicine – a textbook which provides clinicians with a concise description of the fundamental tenets that define aesthetic medicine. The chapter on ZERONA elucidates the subtle therapeutic mechanism that enables this technology to abate unwanted inches in as little as two weeks. The chapter discusses the extensive histological studies, the early pilot investigations, and the level 1c clinical study, that were all performed to demonstrate the safety and efficacy of ZERONA.

DOWNLOAD COMPLETE JOURNAL ARTICLE

Application of Low-Level Laser Therapy for Noninvasive Body Contouring
LASERS IN SURGERY & MEDICINE 44:211 - 217 (2012)

Jackson et al. (2012) completed a 689 patient retrospective study to discern whether the non-invasive contouring subsequent to Zerona was a result of simple lipid/fluid redistribution. The authors applied treatment across the waist, hips, and thighs, and recorded circumferential measurements along treated and non-treated, systemic regions: neck, breast, arms, and knees. The authors reported a statistically significant mean loss of 3.27 inches across the waist, hips, and thighs. Just as important, each systemic, non-treated area demonstrated a statistically significant circumferential reduction, which has dispelled the theory of fluid redistribution.

DOWNLOAD COMPLETE JOURNAL ARTICLE